RxDoctor Payments Data

Cynthia Rutledge, DO

Family Medicine · Big Spring, TXNPI 1043219439

Payments from drug & device makers

$4,563in general payments, 2019–2025

Across 273 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$833
  • AbbVie$733
  • Boehringer Ingelheim$406
  • Lilly USA, LLC$199
  • Pfizer$185
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$4,563100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,563 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$58,829
Medicare patients
150
Services billed
935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept12$92,859
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$50,160
EliquisApixaban21$26,583
OzempicSemaglutide13$19,851
JardianceEmpagliflozin18$19,179
MyrbetriqMirabegron24$14,357
JanuviaSitagliptin Phosphate12$13,366
LinzessLinaclotide11$5,709
Atorvastatin Calcium217$2,437
Albuterol Sulfate HfaAlbuterol Sulfate58$1,883
Levothyroxine Sodium215$1,834
Lisinopril201$1,166
Gabapentin46$1,033
Nadolol11$1,025
Rosuvastatin Calcium82$997

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$125$50,16060 claims
PfizerEliquis$185$26,58321 claims
Novo NordiskOzempic$833$19,85113 claims
Boehringer IngelheimJardiance$406$19,17918 claims
MerckJanuvia$52$13,36612 claims
AbbVieLinzess$733$5,70911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Big Spring

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →